These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A pharmacological profile of the high-affinity GluK5 kainate receptor. Møllerud S; Kastrup JS; Pickering DS Eur J Pharmacol; 2016 Oct; 788():315-320. PubMed ID: 27373850 [TBL] [Abstract][Full Text] [Related]
3. Structure and Affinity of Two Bicyclic Glutamate Analogues at AMPA and Kainate Receptors. Møllerud S; Pinto A; Marconi L; Frydenvang K; Thorsen TS; Laulumaa S; Venskutonytė R; Winther S; Moral AMC; Tamborini L; Conti P; Pickering DS; Kastrup JS ACS Chem Neurosci; 2017 Sep; 8(9):2056-2064. PubMed ID: 28691798 [TBL] [Abstract][Full Text] [Related]
4. Binding site and interlobe interactions of the ionotropic glutamate receptor GluK3 ligand binding domain revealed by high resolution crystal structure in complex with (S)-glutamate. Venskutonytė R; Frydenvang K; Gajhede M; Bunch L; Pickering DS; Kastrup JS J Struct Biol; 2011 Dec; 176(3):307-14. PubMed ID: 21907808 [TBL] [Abstract][Full Text] [Related]
5. Binding and selectivity of the marine toxin neodysiherbaine A and its synthetic analogues to GluK1 and GluK2 kainate receptors. Unno M; Shinohara M; Takayama K; Tanaka H; Teruya K; Doh-ura K; Sakai R; Sasaki M; Ikeda-Saito M J Mol Biol; 2011 Oct; 413(3):667-83. PubMed ID: 21893069 [TBL] [Abstract][Full Text] [Related]
6. Kainate induces various domain closures in AMPA and kainate receptors. Venskutonytė R; Frydenvang K; Hald H; Rabassa AC; Gajhede M; Ahring PK; Kastrup JS Neurochem Int; 2012 Sep; 61(4):536-45. PubMed ID: 22425692 [TBL] [Abstract][Full Text] [Related]
7. Mapping the ligand binding sites of kainate receptors: molecular determinants of subunit-selective binding of the antagonist [3H]UBP310. Atlason PT; Scholefield CL; Eaves RJ; Mayo-Martin MB; Jane DE; Molnár E Mol Pharmacol; 2010 Dec; 78(6):1036-45. PubMed ID: 20837679 [TBL] [Abstract][Full Text] [Related]
9. Agonist binding to the GluK5 subunit is sufficient for functional surface expression of heteromeric GluK2/GluK5 kainate receptors. Fisher JL; Housley PR Cell Mol Neurobiol; 2013 Nov; 33(8):1099-108. PubMed ID: 23975096 [TBL] [Abstract][Full Text] [Related]
10. Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity. Mayer ML Neuron; 2005 Feb; 45(4):539-52. PubMed ID: 15721240 [TBL] [Abstract][Full Text] [Related]
11. Kainate receptor channel opening and gating mechanism. Gangwar SP; Yelshanskaya MV; Nadezhdin KD; Yen LY; Newton TP; Aktolun M; Kurnikova MG; Sobolevsky AI Nature; 2024 Jun; 630(8017):762-768. PubMed ID: 38778115 [TBL] [Abstract][Full Text] [Related]
12. Full domain closure of the ligand-binding core of the ionotropic glutamate receptor iGluR5 induced by the high affinity agonist dysiherbaine and the functional antagonist 8,9-dideoxyneodysiherbaine. Frydenvang K; Lash LL; Naur P; Postila PA; Pickering DS; Smith CM; Gajhede M; Sasaki M; Sakai R; Pentikaïnen OT; Swanson GT; Kastrup JS J Biol Chem; 2009 May; 284(21):14219-29. PubMed ID: 19297335 [TBL] [Abstract][Full Text] [Related]
13. The neurotoxin domoate causes long-lasting inhibition of the kainate receptor GluK5 subunit. Fisher JL Neuropharmacology; 2014 Oct; 85():9-17. PubMed ID: 24859608 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the GluK1 ligand-binding domain with kainate and the full-spanning positive allosteric modulator BPAM538. Bay Y; Cabello FJM; Koens CC; Frantsen SM; Pickering DS; Frydenvang K; Francotte P; Pirotte B; Kristensen AS; Bowie D; Kastrup JS J Struct Biol; 2024 Sep; 216(3):108113. PubMed ID: 39079583 [TBL] [Abstract][Full Text] [Related]
15. The Structure of a High-Affinity Kainate Receptor: GluK4 Ligand-Binding Domain Crystallized with Kainate. Kristensen O; Kristensen LB; Møllerud S; Frydenvang K; Pickering DS; Kastrup JS Structure; 2016 Sep; 24(9):1582-9. PubMed ID: 27524200 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological activity of C10-substituted analogs of the high-affinity kainate receptor agonist dysiherbaine. Lash-Van Wyhe LL; Postila PA; Tsubone K; Sasaki M; Pentikäinen OT; Sakai R; Swanson GT Neuropharmacology; 2010 Mar; 58(3):640-9. PubMed ID: 19962997 [TBL] [Abstract][Full Text] [Related]
17. Assembly and Trafficking of Homomeric and Heteromeric Kainate Receptors with Impaired Ligand Binding Sites. Scholefield CL; Atlason PT; Jane DE; Molnár E Neurochem Res; 2019 Mar; 44(3):585-599. PubMed ID: 30302614 [TBL] [Abstract][Full Text] [Related]